A highly conserved redox-active Mx(2)CWx(6)R motif regulates Zap70 stability and activity.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Poltorak, Mateusz P
Brinkmann, Melanie M
MetadataShow full item record
Abstractζ-associated protein of 70 kDa (Zap70) is crucial for T-cell receptor (TCR) signaling. Loss of Zap70 in both humans and mice results in severe immunodeficiency. On the other hand, the expression of Zap70 in B-cell malignancies correlates with the severity of the disease. Because of its role in immune-related disorders, Zap70 has become a therapeutic target for the treatment of human diseases. It is well-established that the activity/expression of Zap70 is regulated by post-translational modifications of crucial amino acids including the phosphorylation of tyrosines and the ubiquitination of lysines. Here, we have investigated whether also oxidation of cysteine residues regulates Zap70 functions. We have identified C575 as a major sulfenylation site of Zap70. A C575A substitution results in protein instability, reduced activity, and increased dependency on the Hsp90/Cdc37 chaperone system. Indeed, Cdc37 overexpression reconstituted partially the expression but fully the function of Zap70C575A. C575 lies within a Mx(2)CWx(6)R motif which is highly conserved among almost all human tyrosine kinases. Mutation of any of the conserved amino acids, but not of a non-conserved residue preceding the cysteine, also results in Zap70 instability. Collectively, we have identified a new redox-active motif which is crucial for the regulation of Zap70 stability/activity. We believe that this motif has the potential to become a novel target for the development of therapeutic tools to modulate the expression/activity of kinases.
CitationA highly conserved redox-active Mx(2)CWx(6)R motif regulates Zap70 stability and activity. 2017, 8 (19):30805-30816 Oncotarget
AffiliationHelmholtz Centre of infection research, Inhoffenstr. 7, 38124 Braunschweig, Germany.
Collectionsjunior research group immunomodulation (VIMM)
The following license files are associated with this item:
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by-nc-sa/4.0/
- A novel Zap70 mutation with reduced protein stability demonstrates the rate-limiting threshold for Zap70 in T-cell receptor signalling.
- Authors: Cauwe B, Tian L, Franckaert D, Pierson W, Staats KA, Schlenner SM, Liston A
- Issue date: 2014 Mar
- Hypomorphic mutation of ZAP70 in human results in a late onset immunodeficiency and no autoimmunity.
- Authors: Picard C, Dogniaux S, Chemin K, Maciorowski Z, Lim A, Mazerolles F, Rieux-Laucat F, Stolzenberg MC, Debre M, Magny JP, Le Deist F, Fischer A, Hivroz C
- Issue date: 2009 Jul
- T cell receptor dwell times control the kinase activity of Zap70.
- Authors: Klammt C, Novotná L, Li DT, Wolf M, Blount A, Zhang K, Fitchett JR, Lillemeier BF
- Issue date: 2015 Sep
- Otud7b facilitates T cell activation and inflammatory responses by regulating Zap70 ubiquitination.
- Authors: Hu H, Wang H, Xiao Y, Jin J, Chang JH, Zou Q, Xie X, Cheng X, Sun SC
- Issue date: 2016 Mar 7
- Regulation of T cell development by c-Cbl: essential role of Lck.
- Authors: Chiang YJ, Hodes RJ
- Issue date: 2015 May